Barings’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,868
| Closed | -$862K | – | 653 |
|
|
2020
Q2 | $862K | Hold |
4,868
| – | – | 0.03% | 307 |
|
|
2020
Q1 | $862K | Sell |
4,868
-280
| -5% | -$52.7K | 0.03% | 307 |
|
|
2019
Q4 | $984K | Buy |
5,148
+1,304
| +34% | +$235K | 0.03% | 367 |
|
|
2019
Q3 | $647K | Buy |
3,844
+11
| +0.3% | +$1.79K | 0.01% | 448 |
|
|
2019
Q2 | $642K | Sell |
3,833
-8,568
| -69% | -$1.19M | 0.01% | 458 |
|
|
2019
Q1 | $1.81M | Sell |
12,401
-3,894
| -24% | -$565K | 0.04% | 296 |
|
|
2018
Q4 | $2.18M | Buy |
16,295
+1,124
| +7% | +$184K | 0.04% | 249 |
|
|
2018
Q3 | $2.89M | Sell |
15,171
-1,878
| -11% | -$345K | 0.04% | 270 |
|
|
2018
Q2 | $2.84M | Sell |
17,049
-52,697
| -76% | -$8.46M | 0.04% | 281 |
|
|
2018
Q1 | $11.7M | Buy |
69,746
+54,037
| +344% | +$9.06M | 0.17% | 101 |
|
|
2017
Q4 | $2.57M | Buy |
15,709
+4,660
| +42% | +$836K | 0.03% | 334 |
|
|
2017
Q3 | $2.26M | Sell |
11,049
-430
| -4% | -$100K | 0.04% | 289 |
|
|
2017
Q2 | $2.79M | Sell |
11,479
-8,610
| -43% | -$2.02M | 0.08% | 224 |
|
|
2017
Q1 | $4.8M | Hold |
20,089
| – | – | 0.1% | 156 |
|
|
2016
Q4 | $4.22M | Buy |
20,089
+19,180
| +2,110% | +$3.97M | 0.11% | 120 |
|
|
2016
Q3 | $209K | Sell |
909
-7,250
| -89% | -$1.77M | 0.01% | 755 |
|
|
2016
Q2 | $1.89M | Buy |
8,159
+6,591
| +420% | +$1.52M | 0.05% | 321 |
|
|
2016
Q1 | $420K | Sell |
1,568
-3,160
| -67% | -$905K | 0.01% | 722 |
|
|
2015
Q4 | $1.48M | Sell |
4,728
-11,480
| -71% | -$3.42M | 0.04% | 374 |
|
|
2015
Q3 | $4.41M | Sell |
16,208
-9,670
| -37% | -$2.97M | 0.11% | 124 |
|
|
2015
Q2 | $7.85M | Sell |
25,878
-1,900
| -7% | -$567K | 0.24% | 79 |
|
|
2015
Q1 | $8.27M | Buy |
27,778
+12,102
| +77% | +$3.45M | 0.19% | 70 |
|
|
2014
Q4 | $4.04M | Buy |
15,676
+2,200
| +16% | +$550K | 0.09% | 171 |
|
|
2014
Q3 | $3.25M | Buy |
13,476
+5,759
| +75% | +$1.29M | 0.07% | 203 |
|
|
2014
Q2 | $1.72M | Sell |
7,717
-1,600
| -17% | -$331K | 0.05% | 353 |
|
|
2014
Q1 | $1.92M | Sell |
9,317
-420
| -4% | -$83.2K | 0.06% | 301 |
|
|
2013
Q4 | $1.64M | Buy |
+9,737
| New | +$1.52M | 0.07% | 309 |
|
|
2013
Q3 | – | Sell |
-7,967
| Closed | -$1.01M | – | 988 |
|
|
2013
Q2 | $1.01M | Buy |
+7,967
| New | +$902K | 0.05% | 411 |
|
Other funds holding AGN
Barings's AGN Position: Q3 2020 in Review
Barings sold out of Allergan plc (AGN) in Q3 2020, closing a stake of 4,868 shares — an estimated $862K sold.
Barings first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $11.7M in Q1 2018. 3 funds tracked by Wall St. Rank hold AGN as of Q3 2020.
- Barings reported no remaining Allergan plc position as of Q3 2020 after selling out during the quarter.
- Barings sold 4,868 Allergan plc shares in Q3 2020, an estimated $862K.
- Barings first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Barings's Allergan plc position peaked at $11.7M in Q1 2018.
- 3 funds tracked by Wall St. Rank held Allergan plc as of Q3 2020.
Based on Barings's 13F filing for Q3 2020, filed 12 Nov 2020.